BIS Notifies New Quality Standards for Homeopathic Medicines (Effective April 30, 2026)
In a significant step towards strengthening the quality and consistency of homoeopathic medicines in India, the Bureau of Indian Standards (BIS) has notified three new quality standards for homoeopathic medicines. These standards, established on October 30, 2025, will come into effect from April 30, 2026.
The initiative aims to ensure uniformity, safety, and high-quality benchmarks in the manufacturing of raw materials and mother tinctures, thereby enhancing trust and reliability in homoeopathic therapeutics.
Key Highlights of the 2026 Standards
1. Focus Areas
The newly introduced standards specifically address:
- Preparation of mother tinctures (base extracts)
- Quality and processing of raw materials
- Standardization of sugar of milk (lactose) used in homoeopathy
2. Implementation Timeline
- Standards were notified on October 30, 2025
- They will become mandatory from April 30, 2026
- Existing/previous standards will be withdrawn post implementation
3. Objective
The primary goals of these standards include:
- Eliminating variations in manufacturing processes
- Ensuring consistent product quality
- Strengthening the quality control framework for homoeopathic medicines in India
4. Regulatory Significance
These updates are aligned with India’s evolving regulatory landscape for AYUSH systems, reinforcing the importance of:
- Standardized manufacturing practices
- Compliance with defined quality benchmarks
- Greater accountability within the homoeopathic pharmaceutical sector
A Step Towards Global Alignment
The introduction of these standards reflects a broader national effort to elevate traditional medicine systems to international quality benchmarks. Initiatives such as the Ayush Quality Mark further complement this move, ensuring improved patient safety, product reliability, and global acceptance of homoeopathic medicines.
Conclusion
With the enforcement of these new BIS standards, India takes a decisive step towards modernizing homoeopathic drug manufacturing, ensuring that quality, safety, and consistency remain at the forefront of patient care.
